Profile
Nathan Chen is currently the Vice President of Regulatory Affairs at LianBio.
Prior to this, he worked as the Head of Immunology & Inflammation at GSK Plc from 2018 to 2020 and as the Director of Regional Clinical Development at Boehringer Ingelheim Corp.
He holds graduate degrees from Purdue University, Rensselaer Polytechnic Institute, and the State University of New York at Albany.
Nathan Chen active positions
Companies | Position | Start |
---|---|---|
LIANBIO | General Counsel | 31/01/2020 |
Former positions of Nathan Chen
Companies | Position | End |
---|---|---|
GSK PLC | Corporate Officer/Principal | 31/01/2020 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
Training of Nathan Chen
Purdue University | Graduate Degree |
Rensselaer Polytechnic Institute | Graduate Degree |
State University of New York at Albany | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
GSK PLC | Health Technology |
LIANBIO | Health Technology |
Private companies | 1 |
---|---|
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
- Stock Market
- Insiders
- Nathan Chen